Home › Companies › ADMA BIOLOGICS INC. › 2024-2025

ADMA BIOLOGICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and ADMA BIOLOGICS INC.’s Form 8-K, filed June 4, 2025 (Item 5.07 on EDGAR). Page generated October 18, 2026.

  • 8Reported items
  • 365Asset managers
  • 2,852Fund votes
  • June 4, 2025Meeting date

Results at a glance

Meeting of June 4, 2025: 4 items on ADMA BIOLOGICS INC.’s Form 8-K, filed June 4, 2025: 4 without a stated outcome.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2024-2025 2025-2026

Explore ADMA BIOLOGICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by ADMA BIOLOGICS INC.

These tallies are ADMA BIOLOGICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 4, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ADMA BIOLOGICS INC. — official shareholder meeting results, meeting held June 4, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Jerrold B. Grossman D.P.S. 165,120,823---- 16,472,08123,427,635 91%Not verified—
Elect Director: Lawrence P. Guiheen 133,835,725---- 47,757,17923,427,635 74%Not verified—
2. The ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 204,623,833269,649127,057 ---- 99.8%Not verified—
3. The approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers ("Say-on-Pay"); and 161,456,98019,869,072266,852 --23,427,635 89%Not verified—

Source: ADMA BIOLOGICS INC., Form 8-K, filed with the SEC on June 4, 2025 — read the filing on EDGAR.

How asset managers voted at the ADMA BIOLOGICS INC. 2024-2025 meeting

Each item below shows how the 365 asset managers that disclosed a ADMA BIOLOGICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ADMA BIOLOGICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Lawrence P. Guiheen

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

74% Majority: yes · of votes cast

FOR 74%WITHHELD
FOR: 133,835,725WITHHELD: 47,757,179
Details: description as filed, official tally, votes by 112 asset managers

Description as filed by funds: To elect the following Class III directors for a term expiring at the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Lawrence P. Guiheen

ADMA BIOLOGICS INC.’s own tally for this item (“Elect Director: Lawrence P. Guiheen”): 133,835,725 for, 47,757,179 withheld, per its Form 8-K filed June 4, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 74% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 112 asset managers below reported 77,948,105 for, 26,691,913 withheld, 4,022 abstained.

FORWITHHOLD
FOR: 77,948,105ABSTAIN: 4,022WITHHOLD: 26,691,913
Largest asset managers voting on “To elect the following Class III directors for a term expiring at the 2028 Annual Meeting of Stockholders or u” at ADMA BIOLOGICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock25,682,1320 0435,063For
Vanguard16,321,7170 7912,338For
Fidelity7,532,5220 00For
Invesco00 07,437,984Withhold
State Street52,8170 06,167,686Withhold
TIAA00 03,467,129Withhold
OBERWEIS FUNDS3,342,6000 00For
Dimensional2,659,8800 00For
American Century2,409,8240 00For
Charles Schwab2,292,6840 00For
Allspring2,177,5170 00For
Thrivent1,851,0360 00For
T. Rowe Price00 01,577,442Withhold
Jackson National101,1980 01,470,174Mixed
Lord Abbett1,419,7660 00For
Calamos1,408,0780 00For
Putnam1,366,7640 00For
Federated Hermes1,074,8130 00For
Waddell & Reed00 0897,194Withhold
Brighthouse89,5950 0687,799Mixed
Nuveen00 0730,657Withhold
Equitable364,8530 0256,270Mixed
Royce612,2410 00For
Voya611,3990 00For
Columbia Threadneedle00 0579,761Withhold

Showing the 25 largest of 112 asset managers. See all 112 in the interactive database.

2. To elect the following Class III directors for a term expiring at the 2028 Annual Meeting…: Jerrold B. Grossman D.P.S.

No official matchDIRECTOR ELECTIONS

89% of fund votes cast · no official result

FOR
Details: description as filed, votes by 79 asset managers

Description as filed by funds: To elect the following Class III directors for a term expiring at the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jerrold B. Grossman D.P.S.

The 79 asset managers below reported 64,382,576 for, 8,301,359 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 64,382,576WITHHOLD: 8,301,359
Largest asset managers voting on “To elect the following Class III directors for a term expiring at the 2028 Annual Meeting of Stockholders or u” at ADMA BIOLOGICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard16,315,1040 00For
Fidelity7,532,5220 00For
Invesco7,437,9840 00For
State Street52,8170 06,167,686Withhold
TIAA3,467,1290 00For
OBERWEIS FUNDS3,342,6000 00For
Dimensional2,659,8800 00For
American Century2,409,8240 00For
Charles Schwab2,292,6840 00For
Allspring2,177,5170 00For
Thrivent1,851,0360 00For
T. Rowe Price00 01,577,442Withhold
Lord Abbett1,419,7660 00For
Putnam1,366,7640 00For
Federated Hermes1,074,8130 00For
Waddell & Reed897,1940 00For
Nuveen730,6570 00For
Equitable621,1230 00For
Royce612,2410 00For
Voya611,3990 00For
Columbia Threadneedle579,7610 00For
DRIEHAUS MUTUAL FUNDS562,7420 00For
Russell Investments556,0540 00For
AIG/SunAmerica545,1640 00For
MassMutual485,7610 00For

Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.

3. Election of Class III Director for a term expiring at the 2028 Annual Meeting of…: Jerrold B. Grossman D.P.S.

No official matchDIRECTOR ELECTIONS

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 33 asset managers

Description as filed by funds: Election of Class III Director for a term expiring at the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jerrold B. Grossman D.P.S.

The 33 asset managers below reported 31,261,716 for, 27,682 withheld, 3,981 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 31,261,716ABSTAIN: 3,981WITHHOLD: 27,682
Largest asset managers voting on “Election of Class III Director for a term expiring at the 2028 Annual Meeting of Stockholders or until their s” at ADMA BIOLOGICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock26,117,1950 00For
Jackson National1,571,3720 00For
Calamos1,408,0780 00For
QUANTITATIVE MASTER SERIES LLC383,7990 00For
EA Series Trust293,7980 00For
CARILLON SERIES TRUST198,3750 00For
ETF Series Solutions140,3390 00For
TRUST FOR PROFESSIONAL MANAGERS120,8620 00For
John Hancock120,6420 00For
Securian Funds Trust119,7400 00For
JPMorgan111,8730 00For
Innovator ETFs Trust106,5770 00For
HUSSMAN INVESTMENT TRUST105,0000 00For
Zacks Trust84,0410 00For
Allianz79,1360 00For
Bridge Builder Trust44,8770 027,682Mixed
MASTER INVESTMENT PORTFOLIO55,8130 00For
RBC FUNDS TRUST47,9200 00For
BUFFALO FUNDS47,8700 00For
Exchange Place Advisors Trust30,4800 00For
Vanguard18,9930 380For
Northern Lights Fund Trust IV17,6120 00For
TIMOTHY PLAN12,3200 00For
Pacer Funds Trust8,1080 00For
SARATOGA ADVANTAGE TRUST5,3920 00For

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

4. Elect Director Jerrold B. Grossman

No official matchDIRECTOR ELECTIONS

98% of fund votes cast · no official result

FOR
Details: votes by 4 asset managers

The 4 asset managers below reported 654,430 for, 12,296 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 654,430WITHHOLD: 12,296
Largest asset managers voting on “Elect Director Jerrold B. Grossman” at ADMA BIOLOGICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Brighthouse451,0460 00For
Empower182,1580 00For
FORUM FUNDS II21,2260 00For
CLEARWATER INVESTMENT TRUST00 012,296Withhold

5. 3. The approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers…

Outcome not verifiedFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 10 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%
FOR: 161,456,980AGAINST: 19,869,072
Details: description as filed, official tally, votes by 363 asset managers

Description as filed by funds: To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.

ADMA BIOLOGICS INC.’s own tally for this item (“3. The approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers ("Say-on-Pay"); and”): 161,456,980 for, 19,869,072 against, per its Form 8-K filed June 4, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 112 asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.” at ADMA BIOLOGICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock26,117,1950 00For
Vanguard16,321,78612,347 10For
Fidelity7,532,5220 00For
Invesco07,437,984 00Against
State Street6,218,1732,330 00For
TIAA3,467,1290 00For
OBERWEIS FUNDS3,342,6000 00For
Dimensional2,659,8800 00For
American Century02,409,824 00Against
Charles Schwab2,292,6840 00For
Allspring2,177,5170 00For
Thrivent1,851,0360 00For
T. Rowe Price1,577,4420 00For
Jackson National650,327921,045 00Mixed
Lord Abbett1,419,7660 00For
Calamos1,408,0780 00For
Putnam1,366,7640 00For
Federated Hermes1,074,8130 00For
Waddell & Reed897,1940 00For
Brighthouse291,928451,046 34,4200Mixed
Nuveen730,6570 00For
Equitable621,1230 00For
Royce612,2410 00For
Voya611,3990 00For
Columbia Threadneedle579,7610 00For

Fund voting reports, all 112 managers: 92,744,866 for, 12,161,048 against, 139,421 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 282 asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.” at ADMA BIOLOGICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
State Street10,732,2342,895 00For
Invesco010,155,884 00Against
BlackRock8,018,92373,823 00For
GEODE CAPITAL MANAGEMENT, LLC5,690,6800 00For
Nuveen4,844,0290 00For
Fidelity3,363,2640 00For
OBERWEIS ASSET MANAGEMENT INC/3,359,1500 00For
J O HAMBRO CAPITAL MANAGEMENT LTD2,918,9440 00For
Allspring2,908,3400 00For
American Century02,859,757 00Against
Charles Schwab2,479,6970 00For
Two Sigma2,334,0170 00For
B Group, Inc.2,316,0640 00For
T. Rowe Price2,245,9840 00For
Northern Trust2,177,5330 00For
Renaissance2,131,6470 00For
Thrivent1,865,4820 00For
DRIEHAUS CAPITAL MANAGEMENT LLC1,703,0570 00For
Ranger Investment Management, L.P.1,694,7450 00For
MELLON INVESTMENTS Corp1,675,4590 00For
LORD, ABBETT & CO. LLC1,646,0590 00For
Putnam1,548,3420 00For
Russell Investments1,405,3800 00For
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST1,335,0330 00For
PRINCIPAL GLOBAL INVESTORS1,293,8670 00For

Institutional-manager reports, all 282 managers: 92,391,937 for, 15,800,585 against, 45 not voted, 258,464 1 year. Showing the 25 largest; see all in the interactive database.

6. To determine, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation of the…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 4 wordings of this item as funds reported it.

99.6% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: description as filed, votes by 346 asset managers

Description as filed by funds: To determine, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation of the Company's named executive officers.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 109 asset managers voting on “To determine, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation of ” at ADMA BIOLOGICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock00 00--
Vanguard00 00--
Fidelity00 00--
Invesco00 00--
State Street00 00--
TIAA00 00--
OBERWEIS FUNDS00 00--
Dimensional00 00--
American Century00 00--
Charles Schwab00 00--
Allspring00 00--
Thrivent00 00--
T. Rowe Price00 00--
Jackson National00 00--
Lord Abbett00 00--
Calamos00 00--
Putnam00 00--
Federated Hermes00 00--
Waddell & Reed00 00--
Nuveen00 00--
Equitable00 00--
Royce00 00--
Voya00 00--
Columbia Threadneedle00 00--
DRIEHAUS MUTUAL FUNDS00 00--

Fund voting reports, all 109 managers: 137,066 for, 34,420 abstained, 100,953,090 1 year, 2,807,201 3 year, 105,001 unknown, 2 2 year. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 267 asset managers voting on “To determine, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation of ” at ADMA BIOLOGICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
State Street00 00--
Invesco00 00--
BlackRock00 00--
GEODE CAPITAL MANAGEMENT, LLC00 00--
Nuveen00 00--
Fidelity00 00--
OBERWEIS ASSET MANAGEMENT INC/00 00--
J O HAMBRO CAPITAL MANAGEMENT LTD00 00--
Allspring00 00--
American Century00 00--
Charles Schwab00 00Not Voted
Two Sigma00 00--
T. Rowe Price00 00--
Northern Trust00 00--
Renaissance00 00--
Thrivent00 00--
DRIEHAUS CAPITAL MANAGEMENT LLC00 00--
Ranger Investment Management, L.P.00 00--
MELLON INVESTMENTS Corp00 00--
LORD, ABBETT & CO. LLC00 00--
Putnam00 00--
Russell Investments00 00--
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST00 00--
PRINCIPAL GLOBAL INVESTORS00 00--
Federated Hermes00 00--

Institutional-manager reports, all 267 managers: 1,525,900 for, 5,670 against, 45 not voted, 101,020,488 1 year, 672,885 3 year, 108,007 2 year. Showing the 25 largest; see all in the interactive database.

7. Advisory Vote on Say on Pay Frequency

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

100% Fund and manager reports combined; may count the same shares twice · no official result

FOR1 YEAR
Details: votes by 10 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 4 asset managers voting on “Advisory Vote on Say on Pay Frequency” at ADMA BIOLOGICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Brighthouse00 00--
Empower00 00--
FORUM FUNDS II00 00--
CLEARWATER INVESTMENT TRUST00 00--

Fund voting reports, all 4 managers: 666,726 1 year.

Institutional-manager reports: 6 asset managers voting on “Advisory Vote on Say on Pay Frequency” at ADMA BIOLOGICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Ophir Asset Management Pty Ltd1,154,9890 00For
JPMorgan00 00--
Ausbil Investment Management Ltd00 00--
APG Asset Management US Inc.00 00--
TD ASSET MANAGEMENT INC75,5720 00For
Desjardins Global Asset Management Inc.00 00--

Institutional-manager reports, all 6 managers: 1,230,561 for, 610,365 1 year.

8. 2. The ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for…

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 204,623,833AGAINST: 269,649
Details: description as filed, official tally, votes by 113 asset managers

Description as filed by funds: To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.

ADMA BIOLOGICS INC.’s own tally for this item (“2. The ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 204,623,833 for, 269,649 against, per its Form 8-K filed June 4, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 113 asset managers below reported 104,951,449 for, 0 against, 34,420 abstained.

FOR
FOR: 104,951,449AGAINST: 0ABSTAIN: 34,420
Largest asset managers voting on “To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the f” at ADMA BIOLOGICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock26,117,1950 00For
Vanguard16,334,1340 00For
Fidelity7,532,5220 00For
Invesco7,437,9840 00For
State Street6,220,5030 00For
TIAA3,467,1290 00For
OBERWEIS FUNDS3,342,6000 00For
Dimensional2,659,8800 00For
American Century2,409,8240 00For
Charles Schwab2,292,6840 00For
Allspring2,177,5170 00For
Thrivent1,851,0360 00For
T. Rowe Price1,577,4420 00For
Jackson National1,571,3720 00For
Lord Abbett1,419,7660 00For
Calamos1,408,0780 00For
Putnam1,366,7640 00For
Federated Hermes1,074,8130 00For
Waddell & Reed897,1940 00For
Brighthouse742,9740 34,4200For
Nuveen730,6570 00For
Equitable621,1230 00For
Royce612,2410 00For
Voya611,3990 00For
Columbia Threadneedle579,7610 00For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

Largest ADMA BIOLOGICS INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 238,532,252 shares outstanding at the time of that meeting.

Fund voting reports: top ADMA BIOLOGICS INC. shareholders by shares voted on “To approve, on a non-binding, advisory basis, the compensation of the Company's named executive…”, 2024-2025
#Asset manager % of shares outstanding
1BlackRock 10.95%
2Vanguard 6.85%
3Fidelity 3.16%
4Invesco 3.12%
5State Street 2.61%
6TIAA 1.45%
7OBERWEIS FUNDS 1.40%
8Dimensional 1.12%
9American Century 1.01%
10Charles Schwab 0.96%
Institutional-manager reports: top ADMA BIOLOGICS INC. shareholders by shares voted on “To approve, on a non-binding, advisory basis, the compensation of the Company's named executive…”, 2024-2025
#Asset manager % of shares outstanding
1State Street 4.50%
2Invesco 4.26%
3BlackRock 3.39%
4GEODE CAPITAL MANAGEMENT, LLC 2.39%
5Nuveen 2.03%
6Fidelity 1.41%
7OBERWEIS ASSET MANAGEMENT INC/ 1.41%
8J O HAMBRO CAPITAL MANAGEMENT LTD 1.22%
9Allspring 1.22%
10American Century 1.20%

Reported ADMA BIOLOGICS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

ADMA BIOLOGICS INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder % outstanding Disclosure
BlackRock 15.63% 13F
Vanguard Group 7.06% 13F
Invesco 5.39% 13F
State Street 4.80% 13F
Morgan Stanley 2.06% 13F
Dimensional Fund Advisors 2.04% 13F
Nuveen 1.91% 13F
Renaissance Technologies 1.49% 13F
FMR (Fidelity) 1.41% 13F

Percentages above are of 238,532,252 shares outstanding, as reported by ADMA BIOLOGICS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ADMA BIOLOGICS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At ADMA BIOLOGICS INC.'s shareholder meeting held June 4, 2025, in the 2024-2025 proxy season, 365 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,852 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, the compensation of the Company's named executive… — FOR was 89% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ADMA BIOLOGICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 4, 2025.

ADMA BIOLOGICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.